Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
DEFINE GPS
1 other identifier
interventional
3,212
17 countries
83
Brief Summary
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Philips pressure guidewires and the SyncVision co-registration system, employing an adaptive design study for interim sample size re-estimation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable coronary-artery-disease
Started Jun 2021
Longer than P75 for not_applicable coronary-artery-disease
83 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2020
CompletedFirst Posted
Study publicly available on registry
June 30, 2020
CompletedStudy Start
First participant enrolled
June 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
ExpectedJanuary 20, 2025
January 1, 2025
5 years
June 23, 2020
January 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Major Adverse Cardiac Events (MACE; composite of cardiac death, target vessel MI (TVMI), or ischemia-driven revascularization) or hospitalization for progressive or unstable angina at 2 years
2 years
Secondary Outcomes (9)
Major Adverse Cardiac Events (MACE; composite of cardiac death, target vessel MI (TVMI), or ischemia-driven revascularization) or hospitalization for progressive or unstable angina
30 days, 1 year
All-cause, cardiac and non-cardiac mortality
30 days, 1 year and 2 years
All MI, target vessel MI, non-target vessel MI, procedural MI, non-procedural MI
30 days, 1 year and 2 years
Ischemia-driven revascularization, including all revascularization, TVR, TLR, non-TLR TVR, and non-TVR
30 days, 1 year and 2 years
Hospitalization for progressive or unstable ischemia
30 days, 1 year and 2 years
- +4 more secondary outcomes
Study Arms (2)
physiologically-guided arm
EXPERIMENTALPhysiologically-guided PCI using the Philips SyncVision system for determining the PCI strategy
angiographically-guided arm
ACTIVE COMPARATORStandard of care angiographically-guided PCI for determining the PCI strategy
Interventions
Intent to use physiologically-guided PCI using the Philips SyncVision system for determining the PCI strategy
Intent to use PCI standard of care angiographically-guided PCI for determining the PCI strategy
Eligibility Criteria
You may qualify if:
- \. Adult men and women (local age of consent) who present with stable or unstable angina, or NSTEMI.
- \. Undergoing cardiac catheterization with planned PCI or possible ad hoc PCI
- \. Following angiography, PCI is indicated in at least one coronary artery\* on the basis of one or more of the following:
- Presenting with NSTE-ACS (unstable angina with ECG changes or cardiac enzyme-positive NSTEMI) with an identified culprit lesion with DS ≥50%;
- One or more angiographic stenoses present with ≥80% stenosis severity by visual estimation;
- One or more angiographic stenoses present with ≥50% to \<80% stenosis severity by visual estimation and an abnormal non-invasive stress test in the distribution of the lesion(s) within the past 60 days;
- One or more angiographic stenoses are present with ≥50% to \<80% stenosis severity by visual estimation and a spot iFR measure ≤0.89 or FFR≤0.80 for borderline iFR..
- Subject is willing to comply with all scheduled visits and tests and has provided informed written consent
You may not qualify if:
- \. STEMI within 30 days
- \. PCI within the prior 12 months, or any PCI planned after the study procedure (other than planned staged procedures of randomized vessels which are allowed)
- \. Prior CABG anytime
- \. Silent ischemia only (i.e. no cardiac symptoms related to coronary artery disease) within the prior 4 weeks
- \. Documented prior iFR pullback performed in any coronary artery including during the qualifying diagnostic angiogram
- \. Any vessel with in-stent restenosis (ISR) requiring treatment
- \. Cardiogenic shock defined as systolic blood pressure \<90 mmHg for \>20 minutes not responding to fluid resuscitation, or need for inotropic, pressor, or device-based hemodynamic support
- \. Presence of unstable ventricular arrhythmias
- \. Heart rate \> 110, including uncontrolled atrial fibrillation (AF)
- \. Decompensated congestive heart failure (NYHA Class IV or Killip Class III or IV)
- \. Chronic total occlusion (CTO) of a target vessel (exception: a CTO may be present in a non-target vessel if it is supplying non-viable myocardium and there is no intent to open the CTO during the index or later procedure)
- \. Coronary anatomy not amenable to pressure wire manipulation due to extreme tortuosity or complexity such that it is unlikely that a pressure wire could be passed to the distal third of the three major epicardial coronary arteries
- \. Any angiographic giant thrombus (i.e., thrombus length \> 3x RVD at lesion)
- \. Any target vessel with \< TIMI III flow
- \. Any target lesion with a reference vessel diameter (RVD) less than 2.25mm except for within the side branch of a bifurcation lesion
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (84)
University of Alabama Birmingham
Birmingham, Alabama, 35294, United States
Pima Heart & Vascular
Tucson, Arizona, 85716, United States
Central Arkansas Veterans Healthcare System (CAVHS)
Little Rock, Arkansas, 72205, United States
Glendale Adventist
Glendale, California, 91206, United States
Colorado Heart and Vascular
Lakewood, Colorado, 80228, United States
Yale University
New Haven, Connecticut, 06520, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Memorial Healthcare
Hollywood, Florida, 33201, United States
Tampa Cardiovascular Innovations and Research
Tampa, Florida, 33607, United States
Emory University Hospital
Atlanta, Georgia, 30322, United States
Northeast Georgia Medical Center
Gainesville, Georgia, 30501, United States
Straub Medical Center
Honolulu, Hawaii, 96813, United States
Carle Foundation Hospital
Urbana, Illinois, 61801, United States
Community Healthcare System
Munster, Indiana, 46321, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Mass General
Boston, Massachusetts, 02114, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Metro Cardiology Consultants
Coon Rapids, Minnesota, 55433, United States
Fairview Health Services
Edina, Minnesota, 55435, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Gates Vascular Institute
Buffalo, New York, 14203, United States
Northwell Health
Lake Success, New York, 11042, United States
Columbia University Medical Center
New York, New York, 10032, United States
St. Francis Hospital
Roslyn, New York, 11576, United States
NC Heart and Vascular Research, LLC
Raleigh, North Carolina, 27607, United States
Summa Health System
Akron, Ohio, 44304, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010, United States
Jefferson Einstein Medical Center
Philadelphia, Pennsylvania, 19141, United States
UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213, United States
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
North Central Heart
Sioux Falls, South Dakota, 57108, United States
Centennial Medical Center
Nashville, Tennessee, 37203, United States
Ascension Saint Thomas
Nashville, Tennessee, 37205, United States
Baylor Scott & White, The Heart Hospital Plano
Plano, Texas, 75093, United States
Sentara Health
Norfolk, Virginia, 23502, United States
Carilion Clinic
Roanoke, Virginia, 24014, United States
Gundersen Health
La Crosse, Wisconsin, 54601, United States
Gosford Hospital
Gosford, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Prince of Wales Hospital
Sydney, New South Wales, Australia
Lake Macquarie Private Hospital
Gateshead, Australia
The Alfred Hospital
Melbourne, Australia
Akademisches Lehrkrankenhaus Feldkirch
Feldkirch, Austria
Royal Columbian Hospital
New Westminster, British Columbia, Canada
Montreal Heart Institute
Montreal, Quebec, Canada
William Osler Health-Brampton Civic Hospital
Brampton, Canada
Hopital du Sacre-Coeur de Montreal
Montreal, Canada
St. Michael's Hospital
Toronto, Canada
Aarhus University Hospital
Aarhus, Denmark
CHU Lille, Institut Coeur Poumon
Lille, France
CHU Nimes Caremeau
Nîmes, France
Vivantes Klinikum im Friedrichshain
Berlin, 10249, Germany
Erlangen University Hospital
Erlangen, Germany
University Hospital Essen
Essen, Germany
Universitsklinik Freiburg
Freiburg im Breisgau, Germany
Hillel Yaffe Medical Center
Hadera, Israel
Shamir Medical Center
Tel Aviv, Israel
Careggi University Hospital
Florence, Italy
Hospital General Querétaro
Querétaro, Mexico
Albert Schweitzer Ziekenhuis / Hartcentum Dordrecht- Gorinchem
Dordrecht, Netherlands
Medisch Spectrum Twente
Enschede, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands
St Antonius Hospital Nieuwegein
Nieuwegein, Netherlands
Radboud University Med Ctr
Nijmegen, Netherlands
Medical University of Warsaw
Warsaw, Poland
Hospital Prof. Doutour Fernando Foneseca
Amadora, Portugal
Sejong General Hospital
Bucheon-si, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Seoul National University Hospital
Seoul, South Korea
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Universitario de Leon
León, Spain
Hospital Clinico San Carlos
Madrid, Spain
Hospital Universitario Marqués de Valdecillas
Santander, Spain
Skane University Hospital
Lund, Sweden
Örebro University Hospital
Örebro, Sweden
Geneva University Hospital
Geneva, Switzerland
University Hospital Southampton
Southampton, Hampshire, S016 6YD, United Kingdom
University Hospital of Wales
Cardiff, Wales, United Kingdom
Royal Bournemouth Hospital
Bournemouth, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allen Jeremias, MD MSC FACC FSCAI
Saint Francis Hospital
- STUDY CHAIR
Gregg W Stone, MD
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2020
First Posted
June 30, 2020
Study Start
June 17, 2021
Primary Completion
June 1, 2026
Study Completion (Estimated)
June 1, 2028
Last Updated
January 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share